Abcam Buys MitoSciences for $6M

Abcam paid $4.2 million in cash and issued $1.8 million in company stock for MitoSciences, which develops mitochondrial antibodies and assays.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.